A Shadow Beneath the Skin
Imagine feeling tired—not normal tiredness, but a fatigue that seeps into your bones, making a morning cup of coffee feel like drinking saltwater. Then comes a fever with no cause, night sweats that soak the pillow twice a night, unexplained weight loss, and a small lump on the neck—a small, hard, painless, and persistent one. You go to the clinic. The doctor touches it and says: "We take a biopsy. It seems... unusual."
That is the starting point for thousands of people around the world who are later diagnosed with Castleman disease—a name that sounds like the title of a detective novel, not a medical diagnosis. There is no single definitive symptom. No blood test can give a definite answer. And no two cases are truly identical—as if the disease writes a new script for each patient.
Three Faces of One Shadow
Castleman disease is not one disease—it is three distinct entities that share the same name but have different natures. First:
Unicentric Castleman disease (UCD)—like a ghost living in one room. It only attacks
one group of lymph nodes, usually in the chest or abdomen. Sometimes it shows no symptoms at all; it is found by chance during a CT scan for another problem. Yet, even though it may seem 'harmless,' UCD can cause organ pressure, shortness of breath, or paraneoplastic syndrome—where the small tumor forces the body to produce hormones or proteins that disrupt the entire body's balance.
Second: HHV-8-associated multicentric Castleman disease. Here, human herpesvirus type 8—which is also closely linked to Kaposi's sarcoma—enters B cells and activates inflammatory pathways like a signal light that never turns off. Its patients are often immunocompromised, especially those with HIV. Third: Idiopathic multicentric Castleman disease (iMCD)—the darkest and most mysterious. No virus can be detected. No universal genetic mutation. But the immune system is in a cytokine storm: interleukin-6 (IL-6), VEGF, TNF-α—proteins that should protect—now act like soldiers turning against their own, attacking organs, damaging bone marrow, flooding the lungs with fluid, and slowly weakening the heart.
Under the Microscope: Beauty That Kills
If you look at the lymph node tissue of a Castleman disease patient under a microscope, you will see a breathtaking beauty. Perfectly round follicles—like bird eggs—surrounded by neatly arranged plasma cell coronas. In the center, excessive vascularization: blood vessels like spider webs growing uncontrollably. This is not chaos—it is a
pathological architecture so specific that pathology experts often say: "Once you see this, you will never forget it forever."
Yet, this beauty is deceptive. Behind the orderly arrangement lies a failure of communication between immune cells—like a band where all members play the right notes, but there is no conductor. As a result: the symphony becomes cacophony. And the body, which should be a fortress, becomes an internal battlefield.
Numbers That Stand Alone in the World
In the United States, the estimated number of new Castleman disease cases each year ranges from 4,300 to 5,200—a number that seems large, but is actually less than
one case per 100,000 people. In Malaysia? No national data. No registry. No specialized referral center. Many cases are reported as 'unclear lymphoma' or 'chronic infection,' causing delayed diagnosis—sometimes for two to three years. During this time, iMCD can lead to organ failure, severe anemia, or potentially fatal deep vein thrombosis.
Yet, here lies a subtle hope: UCD often completely recovers with complete excision surgery. For iMCD, anti-IL-6 therapies such as siltuximab have changed the landscape—transforming patients' lives from 'waiting for complications' to 'living with control.' And for HHV-8-associated MCD, antiviral therapy combined with immunomodulators can suppress the cytokine storm—not cure, but calm.
What We Don't Know—and Why It Matters
The most troubling is not the lack of treatment. The troubling thing is the lack of
understanding. Why does the HHV-8 virus only trigger Castleman in some people? Why do some iMCD patients respond exceptionally well to steroids, while others show no movement at all? Why are women more commonly affected in the unicentric form, but men dominate multicentric cases?
Answers to these questions are not in textbooks. They are in clinical records that have not been analyzed, in tissue samples still stored in freezers, in patient stories that have not yet been recorded—stories about how they learned to recognize the language of their own bodies, how they read changes in skin color, in pulse rhythm, in neck muscle tension that they had never noticed before.
Castleman disease is not just a diagnosis. It is a reminder—that modern medicine still stands before many closed doors. And sometimes, the key to opening them is not the latest technology, but a bold enough question to ask: "Why this, not that?"
And that question—simple, yet heavy—continues to echo, day after day, in treatment rooms, in silent laboratories, and in the hearts of thousands of people still searching for a name for their pain.
---
Reference: Castleman disease — Wikipedia
This Disease Kills Like Cancer—But It's Not Cancer. Why Are Doctors Still Concerned?. Behind a seemingly ordinary swollen lymph node lies a rare disease that tricks the immune system itself—causing the body to kill itself silently. It is not cancer, not an infection, and not autoimmune—but it behaves like all three at once. More surprisingly: each patient is a unique clinical mystery.. A Shadow Beneath the Skin
Imagine feeling tired—not normal tiredness, but a fatigue that seeps into your bones, making a morning cup of coffee feel like drinking saltwater. Then comes a fever with no cause, night sweats that soak the pillow twice a night, unexplained weight loss, and a small lump on the neck—a small, hard, painless, and persistent one. You go to the clinic. The doctor touches it and says: "We take a biopsy. It seems... unusual."
That is the starting point for thousands of people around the world who are later diagnosed with Castleman disease —a name that sounds like the title of a detective novel, not a medical diagnosis. There is no single definitive symptom. No blood test can give a definite answer. And no two cases are truly identical—as if the disease writes a new script for each patient.
Three Faces of One Shadow
Castleman disease is not one disease—it is three distinct entities that share the same name but have different natures. First: Unicentric Castleman disease UCD —like a ghost living in one room. It only attacks one group of lymph nodes, usually in the chest or abdomen. Sometimes it shows no symptoms at all; it is found by chance during a CT scan for another problem. Yet, even though it may seem 'harmless,' UCD can cause organ pressure, shortness of breath, or paraneoplastic syndrome—where the small tumor forces the body to produce hormones or proteins that disrupt the entire body's balance.
Second: HHV-8-associated multicentric Castleman disease . Here, human herpesvirus type 8—which is also closely linked to Kaposi's sarcoma—enters B cells and activates inflammatory pathways like a signal light that never turns off. Its patients are often immunocompromised, especially those with HIV. Third: Idiopathic multicentric Castleman disease iMCD —the darkest and most mysterious. No virus can be detected. No universal genetic mutation. But the immune system is in a cytokine storm : interleukin-6 IL-6 , VEGF, TNF-α—proteins that should protect—now act like soldiers turning against their own, attacking organs, damaging bone marrow, flooding the lungs with fluid, and slowly weakening the heart.
Under the Microscope: Beauty That Kills
If you look at the lymph node tissue of a Castleman disease patient under a microscope, you will see a breathtaking beauty. Perfectly round follicles—like bird eggs—surrounded by neatly arranged plasma cell coronas. In the center, excessive vascularization: blood vessels like spider webs growing uncontrollably. This is not chaos—it is a pathological architecture so specific that pathology experts often say: "Once you see this, you will never forget it forever."
Yet, this beauty is deceptive. Behind the orderly arrangement lies a failure of communication between immune cells—like a band where all members play the right notes, but there is no conductor. As a result: the symphony becomes cacophony. And the body, which should be a fortress, becomes an internal battlefield.
Numbers That Stand Alone in the World
In the United States, the estimated number of new Castleman disease cases each year ranges from 4,300 to 5,200—a number that seems large, but is actually less than one case per 100,000 people . In Malaysia? No national data. No registry. No specialized referral center. Many cases are reported as 'unclear lymphoma' or 'chronic infection,' causing delayed diagnosis—sometimes for two to three years. During this time, iMCD can lead to organ failure, severe anemia, or potentially fatal deep vein thrombosis.
Yet, here lies a subtle hope: UCD often completely recovers with complete excision surgery. For iMCD, anti-IL-6 therapies such as siltuximab have changed the landscape—transforming patients' lives from 'waiting for complications' to 'living with control.' And for HHV-8-associated MCD, antiviral therapy combined with immunomodulators can suppress the cytokine storm—not cure, but calm .
What We Don't Know—and Why It Matters
The most troubling is not the lack of treatment. The troubling thing is the lack of understanding . Why does the HHV-8 virus only trigger Castleman in some people? Why do some iMCD patients respond exceptionally well to steroids, while others show no movement at all? Why are women more commonly affected in the unicentric form, but men dominate multicentric cases?
Answers to these questions are not in textbooks. They are in clinical records that have not been analyzed, in tissue samples still stored in freezers, in patient stories that have not yet been recorded—stories about how they learned to recognize the language of their own bodies, how they read changes in skin color, in pulse rhythm, in neck muscle tension that they had never noticed before.
Castleman disease is not just a diagnosis. It is a reminder—that modern medicine still stands before many closed doors. And sometimes, the key to opening them is not the latest technology, but a bold enough question to ask: "Why this , not that ?"
And that question—simple, yet heavy—continues to echo, day after day, in treatment rooms, in silent laboratories, and in the hearts of thousands of people still searching for a name for their pain.
---
Reference: Castleman disease — Wikipedia https://en.wikipedia.org/wiki/Castleman disease
